Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Communication of fracture risk and treatment benefit in terms of ‘bone health age’ using FRAX or Qfracture

Research output: Contribution to conferenceConference abstract for conferenceCommunication

  1. Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Patientinddragelse- og pårørendeinddragelse i det moderne sundhedsvæsen: Fælles beslutningstagning i et narrativt perspektiv

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducationpeer-review

View graph of relations
Introduction: Communication of absolute and relative risks is challenging despite the development of tools to quickly derive absolute fracture risk estimates from risk factors with or without BMD. We speculated that back-transformation of risks to a risk age could make for a clearer message and at the same time increase agreement between risk algorithms.

Results: The algorithms differed less in estimated bone health age than in percent risk. A 60 years old woman with a maternal history of hip fracture has a predicted major osteoporotic fracture risk equivalent to that of a 71 years (FRAX) or 68 years-old woman (Qfracture). Treatment with 40% risk reduction is equivalent to a reduction in risk age by 10 years in both algorithms, reducing risk age to 62 (FRAX) or 60 years (Qfracture).

Table 1
Assuming no treatment Assuming treatment with 40% risk reduction
FRAX ‘Age’/ 10 years risk Qfracture ‘Age’/ 10 years risk FRAX ‘Age’/ 10 years risk Qfracture ‘Age’/ 10 years risk
Age 60; maternal hip 71/12% 68/6.4% 62/7.2% 60/3.8%
fx + own fracture 85/23% 77/10.7% 74/13.8% 69/6.4%
Age 70; maternal hip 80/18% 80/12.3% 70/10.8% 70/7.4%
fx + own fracture 90+/33% 82/13.3% 82/19.8% 72/8.0%
Conclusions: Conversion of absolute fracture risk to equivalent bone health age is simple and intuitive and can accommodate both baseline BMD and the expected risk reductions on treatment.
Original languageEnglish
Publication date2013
Number of pages1
Publication statusPublished - 2013

ID: 46034405